User profiles for Alasdair M. Barr
Alasdair BarrUniversity of British Columbia Verified email at interchange.ubc.ca Cited by 10831 |
The need for speed: an update on methamphetamine addiction
AM Barr, WJ Panenka, GW MacEwan… - Journal of psychiatry and …, 2006 - jpn.ca
The psychostimulant methamphetamine (MA) is a highly addictive drug that has surged in
popularity over the last decade in North America. A burgeoning number of clandestine drug …
popularity over the last decade in North America. A burgeoning number of clandestine drug …
Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings
…, GW MacEwan, SW Flynn, WG Honer, AM Barr - Drug and alcohol …, 2013 - Elsevier
Methamphetamine (MA) is a highly addictive psychostimulant drug that principally affects
the monoamine neurotransmitter systems of the brain and results in feelings of alertness, …
the monoamine neurotransmitter systems of the brain and results in feelings of alertness, …
Much of late life cognitive decline is not due to common neurodegenerative pathologies
Objective The pathologic indices of Alzheimer disease, cerebrovascular disease, and Lewy
body disease accumulate in the brains of older persons with and without dementia, but the …
body disease accumulate in the brains of older persons with and without dementia, but the …
Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression
… reduce immobility time compared to OVX controls (Barr and Galea, unpublished results). …
degree than that observed in the present study (Barr and Galea, unpublished results). To our …
degree than that observed in the present study (Barr and Galea, unpublished results). To our …
Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis
Background Methamphetamine has long been considered as a neurotoxic substance causing
cognitive deficits. Recently, however, the magnitude and the clinical significance of the …
cognitive deficits. Recently, however, the magnitude and the clinical significance of the …
Stimulation of the ventral subiculum of the hippocampus evokes glutamate receptor‐mediated changes in dopamine efflux in the rat nucleus accumbens
…, CR Yang, SB Floresco, AM Barr… - European Journal of …, 1997 - Wiley Online Library
The effects of electrical stimulation of the ventral subiculum/CA1 region of the hippocampus
on changes in dopamine oxidation current (corresponding to dopamine efflux) in the nucleus …
on changes in dopamine oxidation current (corresponding to dopamine efflux) in the nucleus …
Neuroleptic malignant syndrome: a review from a clinically oriented perspective
Neuroleptic malignant syndrome (NMS) is a rare but potentially life-threatening sideeffect that
can occur in response to treatment with antipsychotic drugs. Symptoms commonly include …
can occur in response to treatment with antipsychotic drugs. Symptoms commonly include …
Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system
JYT Leung, AM Barr, RM Procyshyn, WG Honer… - Pharmacology & …, 2012 - Elsevier
Cardiovascular disease is the leading cause of death in people with severe mental disorders,
and rates are proportionally greater than for other diseases such as cancer. Reports of …
and rates are proportionally greater than for other diseases such as cancer. Reports of …
A 'crash'course on psychostimulant withdrawal as a model of depression
AM Barr, A Markou, AG Phillips - Trends in pharmacological sciences, 2002 - cell.com
Most drugs of abuse generate diverse behavioral and neurochemical effects in mammals.
However, one feature common to many such drugs is the phenomenon of the withdrawal …
However, one feature common to many such drugs is the phenomenon of the withdrawal …
Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of …
AM Barr, AG Phillips - Psychopharmacology, 1999 - Springer
Numerous studies have shown that withdrawal from sustained high doses of psychostimulant
drugs such as cocaine or d-amphetamine produces depressive-like symptoms in both rats …
drugs such as cocaine or d-amphetamine produces depressive-like symptoms in both rats …